Cargando…
Qualitative assessment of anti‐SARS‐CoV‐2 spike protein immunogenicity (QUASI) after COVID‐19 vaccination in older people living with HIV
OBJECTIVES: Effective and safe COVID‐19 vaccines have been developed and have resulted in decreased incidence and severity of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection and can decrease secondary transmission. However, there are concerns about dampened immune responses to...
Autores principales: | Tuan, Jessica J., Zapata, Heidi, Critch‐Gilfillan, Terese, Ryall, Linda, Turcotte, Barbara, Mutic, Suzana, Andrews, Laurie, Roh, Michelle E., Friedland, Gerald, Barakat, Lydia, Ogbuagu, Onyema |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652674/ https://www.ncbi.nlm.nih.gov/pubmed/34632695 http://dx.doi.org/10.1111/hiv.13188 |
Ejemplares similares
-
Long-term quantitative assessment of anti-SARS-CoV-2 spike protein immunogenicity (QUASI) after COVID-19 vaccination in older people living with HIV (PWH)
por: Tuan, Jessica J., et al.
Publicado: (2022) -
HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report
por: Ogbuagu, Onyema, et al.
Publicado: (2023) -
Correction: HIV risk profile and prevention needs of individuals seeking monkeypox (mpox) vaccination in an urban clinic in the U.S.: a brief report
por: Ogbuagu, Onyema, et al.
Publicado: (2023) -
599. Expanding HIV Training in Internal Medicine Residency Program: A Prospect to Meet the HIV Workforce Demand
por: Barakat, Lydia, et al.
Publicado: (2018) -
Dolutegravir/rilpivirine for the treatment of HIV-1 infection
por: Dowers, Ellen, et al.
Publicado: (2018)